SAAVI

AcronymDefinition
SAAVISouth African AIDS Vaccine Initiative
SAAVISouthern Arizona Association for the Visually Impaired (Tucson, AZ)
SAAVISexual Assault and Anti-Violence Information (Utah State University; Logan, UT)
References in periodicals archive ?
Por una parte, se aborda el tema de la identidad etnica, especificamente el que se genera en el ambito de las comunidades, en este sentido, la comunidad indigena en la montana, ya sea hablante del me phaa (tlapaneca), nu saavi (mixteca) o nahua, se ha constituido como un reducto de autonomia frente a la agresion que se vive y se percibe del exterior.
(17) Major PPPs in this field include: IAVI, the AIDS Vaccine Advocacy Coalition (AVAC), CAVD, the Center for AIDS/HIV Vaccine Immunology (CHAVI), GAVI, the African AIDS Vaccine Programme (AAVP), the South African AIDS Vaccine Initiative (SAAVI), and the European and Developing Countries Clinical Trials Partnership (EDCTP).
Conducted jointly by the South African AIDS Vaccine Initiative (SAAVI) and the HIV Vaccine Trials Network (HVTN), the trial is supported by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH).
Acknowledements and disclaimer: The work described here was supported by the South African AIDS Vaccines Initiative (SAAVI) and the National Institutes of Health award (1RO1 A1094586) CHAMPS (Choices for Adolescent Methods of Prevention in South Africa).
The South African Tuberculosis Vaccine Initiative (SATVI), the South African AIDS Vaccine Initiative (SAAVI), the Desmond Tutu HIV Centre (DTHC), the Clinical Infectious Diseases Research Initiative and the Lung and Infection Unit (some of whose work is published in this issue) are world famous for their translational clinical work, most of which is conducted at field sites within the Western Cape.
The South African AIDS Vaccine Initiative (SAAVI) provided support to the clinical trial sites.
The clinical sites developed both through national funding via the South African AIDS Vaccine Initiative (SAAVI) and international funding, such as the National Institutes of Health (NIH)-funded HIV Vaccine Trials Network (HVTN) and the multinational International AIDS Vaccine Initiative (IAVI), were responsible for providing internationally accredited clinical trial sites capable of conducting HIV vaccine trials, from earliest phase through to efficacy, to the highest international standards.
The work of the HIV/AIDS Vaccines Ethics Group is funded by the South African AIDS Vaccine Initiative (SAAVI).
This conceptual research was funded by the South African AIDS Vaccine Initiative (SAAVI).
Three of these are ongoing, namely HVTN 204, a phase II trial assessing the safety and immunogenicity of a multiclade HIV-1 DNA vaccine boosted by a multiclade HIV-1 Ad5 vaccine in HIV-uninfected adults, in which 240 of the 480 participants are South Africans who have received all their vaccinations and are being followed up for long-term safety and immunogenicity; the SAAVI 102/HVTN 073 trial, investigating the multigene sub-type C SAAVI DNAC2 and MVA-C vaccine, a phase I trial currently enrolling participants, of whom 36 out of the 48 will be enrolled in South Africa; and the HVTN 503 phase IIB trial, in which 801 participants are being followed up after further enrolments and vaccinations were halted.
Elise Levendal, chairperson of the South African AIDS Vaccine Initiative (SAAVI), emphasised that without Thailand's excellent community involvement, the trial would not have been possible.